World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03459248
Date of registration: 03/03/2018
Prospective Registration: No
Primary sponsor: Makassed General Hospital
Public title: Metoclopramide-Ondansetron vs. Metoclopramide Therapy for Treatment of Nausea and Vomiting Post Laparoscopic Surgery
Scientific title: Metoclopramide-Ondansetron Dual Therapy vs Metoclopramide Monotherapy for Treatment of Nausea and Vomiting Post Laparoscopic Cholecystectomy
Date of first enrolment: February 15, 2018
Target sample size: 120
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03459248
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Triple (Participant, Care Provider, Investigator).  
Phase:  N/A
Countries of recruitment
Lebanon
Contacts
Name:     Zoher Naja, MD
Address: 
Telephone:
Email:
Affiliation:  Makassed General Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients aging 16 years and above

- Patients undergoing laparoscopic cholecystectomy under General Anesthesia at Makassed
General Hospital

Exclusion Criteria:

- Patients with history of motion sickness

- Patients on previous treatment by anti-emetics for dizziness, vertigo or other causes
of nausea and vomiting

- Patients with any type of allergy to metoclopramide or ondansetron

- Patients refusing to be part of the study (refusal to sign consent)

- Patients on previous treatment by opioids



Age minimum: 16 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Postoperative Nausea and Vomiting
Intervention(s)
Other: Dual therapy
Other: General anesthesia
Other: Monotherapy
Primary Outcome(s)
postoperative nausea and vomiting [Time Frame: 36 hours postoperatively]
Secondary Outcome(s)
Surgeon satisfaction [Time Frame: 36 hours postoperatively]
Patient satisfaction [Time Frame: 36 hours postoperatively]
Secondary ID(s)
122018
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history